GRELINE (anagrelide hydrochloride) 0.5 MG SOLID CAPSULE

GRELINE (anagrelide hydrochloride) 0.5 MG SOLID CAPSULE
Product Description

ANAGRELIDE HCl 0.5 MG CAPSULE (100 CAPS)
GRELİNE is indicated for the treatment of high vascular risk essential thrombocythemia in patients who are unresponsive to hydroxyurea and aspirin therapy, or who develop venous thrombosis, or who experience intolerable anemia and/or leukopenia following the use of hydroxyurea. Additionally, GRELİNE may be used in the treatment of thrombocytosis developing in the course of myeloproliferative diseases (such as myelofibrosis, polycythemia vera, chronic myeloid leukemia, atypical myeloproliferative/myelodysplastic syndrome with thrombocythemia) if a response cannot be achieved with hydroxyurea under the aforementioned conditions.

FARMA-TEK ILAC SAN. Ve TIC. A.S

  • TR
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Pharmaceutical company
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Specifications
  • CAS Registry Number
    58579-51-4
  • Measured In
    piece

FARMA-TEK ILAC SAN. Ve TIC. A.S

  • TR
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Pharmaceutical company
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Out-licensing specialist
Pharmaceutical Company (generic finished products)

More Products from FARMA-TEK ILAC SAN. Ve TIC. A.S (29)

  • BENZADERM (erythromycin + benzoyl peroxide) %3 + %5 TOPICAL GEL

    Product BENZADERM (erythromycin + benzoyl peroxide) %3 + %5 TOPICAL GEL

    ERYTHROMYCIN+ BENZOYL PEROXIDE %3 + %5 TOPICAL GEL (40 g gel containing benzoyl peroxide in a cardboard box, PP plastic jar, 1.6 g erythromycin in a PP plastic bottle, 6 ml of 70% ethyl alcohol in a glass bottle, and a mixing PP plastic stick)

    Indicated for the topical management of acne vulgaris.
  • BENZOXIN (benzoyl peroxide + clindamycin) %5 + %1 TOPICAL GEL

    Product BENZOXIN (benzoyl peroxide + clindamycin) %5 + %1 TOPICAL GEL

    BENZOYL PEROXIDE + CLINDAMYCIN %5 + %1 TOPICAL GEL (25 G TUBE)

    Topical treatment of acne vulgaris in adolescents and adults aged 12 years and older.
  • CITOVIR (valganciclovir hydrochloride) 450 MG FILM TABLET

    Product CITOVIR (valganciclovir hydrochloride) 450 MG FILM TABLET

    VALGANCICLOVIR HCl 450 MG FILM COATED TABLET (60 TABS)

    Indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with Acquired Immune Deficiency Syndrome (AIDS),Indicated for the prevention of cytomegalovirus (CMV) disease in adult and pediatric (0-18 years) patients undergoing soli...
  • DERMIFIN (naftifine hydrochloride) %1 CREAM & SPRAY

    Product DERMIFIN (naftifine hydrochloride) %1 CREAM & SPRAY

    NAFTIFINE HCI 1% CREAM (30 G TUBE)
    NAFTIFINE HCI 1% SPRAY (20 ML BOTTLE)
    For the treatment of mycotic infections of the skin or skin folds (tinea corporis, tinea cruris)
    Interdigital fungal infections (tinea manus, tinea pedis)
    Fungal infections of the nails (onychomycosis)
    Cutaneous c...
  • FEBIND-F (deferasirox) 360 MG FILM COATED TABLET

    Product FEBIND-F (deferasirox) 360 MG FILM COATED TABLET

    Deferasirox 360 MG FILM COATED TABLET (30 TABS)

    FEBİND-F is indicated for the treatment of chronic iron overload (transfusional hemosiderosis) due to blood transfusions in children aged 6 years and above and in adults. This film-coated tablet should not be preferred in the 2-5 age group; instead, ...
  • GLISENIT (glyceryl trinitrate) 1MG/ML IV INFUSION SOLUTION

    Product GLISENIT (glyceryl trinitrate) 1MG/ML IV INFUSION SOLUTION

    GLYCERYL TRINITRATE (NITROGLYCERINE) 10 MG/10 ML SOLUTION FOR INJECTION (10 AMPS)

    GLISENIT is a medication used for the treatment of anginal attacks. GLISENIT is indicated in the following conditions: • Pain in the heart caused by impaired blood flow in the coronary arteries (severe angina pec...
  • GUAGO (guanfacine hydrochloride) 1MG & 2MG & 3MG & 4MG EXTENDED RELEASE TABLET

    Product GUAGO (guanfacine hydrochloride) 1MG & 2MG & 3MG & 4MG EXTENDED RELEASE TABLET

    GUANFACINE HCl 1MG & 2MG & 3MG & 4MG MODIFIED RELEASE TABLET (28 TABS)
    GUAGO is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents aged 6-17 years who have not responded to, cannot tolerate, or for whom stimulant medications are inapp...
  • HIERO (deferiprone) 500 MG FILM COATED TABLET

    Product HIERO (deferiprone) 500 MG FILM COATED TABLET

    DEFERIPRONE 500MG FILM TABLET (100 TABS)
    HIERO monotherapy is used for the treatment of iron overload in patients with observed thalassemia major where chelation therapy is contraindicated or inadequate. • It is indicated for combined use when a single iron chelator is ineffective or when rapid preve...
  • OPILOX (ciclopirox) 80 MG/G NAIL POLISH SET

    Product OPILOX (ciclopirox) 80 MG/G NAIL POLISH SET

    CICLOPIROX 80 MG/G NAIL POLISH (3 G BOTTLE)
    It is indicated in the treatment of fungal infections in nails.
  • POSAKSIN (posaconazole) ORAL SUSPENSION / TABLET

    Product POSAKSIN (posaconazole) ORAL SUSPENSION / TABLET

    POSACONAZOLE 40 MG/ML ORAL SUSPENSION (105 ML BOTTLE), POSACONAZOLE 100 MG ENTERIC TABLET (24&96 TABS)
    It is indicated in the treatment of fungal infections.
  • POTRICAL-B (calcipotriol + betamethasone dipropionate) %0,005 + %0,05 OINTMENT

    Product POTRICAL-B (calcipotriol + betamethasone dipropionate) %0,005 + %0,05 OINTMENT

    CALCIPOTRIOL + BETAMETHASONE DIPROPIONATE 0.005% + 0.05% OINTMENT (30 G TUBE)
    Topical treatment of stable psoriasis vulgaris responsive to topical therapy.
  • PRIDESMO (desmopressin acetate) 60MCG & 120MCG SUBLINGUAL TABLET

    Product PRIDESMO (desmopressin acetate) 60MCG & 120MCG SUBLINGUAL TABLET

    DESMOPRESSIN ACETATE 60 MCG & 120 MCG SUBLINGUAL TABLET (30 TABS)
    In the treatment of primary nocturnal enuresis, starting from the age of 5 in patients who can concentrate urine normally, • For symptomatic treatment of nocturia associated with nocturnal polyuria in adults (e.g., excessive noctur...

FARMA-TEK ILAC SAN. Ve TIC. A.S resources (2)